NALIRIFOX versus gemcitabine plus nab-paclitaxel in Chinese patients with advanced pancreatic adenocarcinoma: a randomized, open-label phase II trial. - Gao C; Zhang Y; Qu X; Chen X; Zhang J; Wu H; Sun M; Zha Y; Wang J; Wang Y; Li Z; Gao J; et al. (Nature communications, 2026)